甲状腺相关性眼病研究新进展  

Development of thyroid-associated ophthalmopathy's study

作　　者：王韧琰[1] 钟勇[1] 

机构地区：[1]北京协和医学院北京协和医院眼科,中国北京市100730

出　　处：《国际眼科杂志》2009年第7期1334-1337,共4页International Eye Science

摘　　要：甲状腺相关性眼病为常见眼眶病,其患病率在成人眼眶病中居首位。研究表明,甲状腺相关眼病是一种与Graves病相关的自身免疫性疾病,其具体发病机制不清。最近的临床和基础研究使我们对该病有了进一步的认识,通过复习相关文献,我们从免疫、病理、遗传等方面的最新研究对甲状腺相关眼病发病机制,临床诊断及治疗新进展进行了综述,并对今后的研究方向进行了展望。Thyroid-associated ophthalmopathy（TAO） is an autoimmune disease, up to now the pathogenesis of which is not very clear. Lately we have known more about TAO by clinical and basic study. This article is to review the pathogenesis of TAO in defferent subjects, such as immunology, pathology and genetics. And to summarize the progress in clinical diagnosis and treatment, also to find new direction in future study.

关 键 词：甲状腺相关性眼病 发病机制 临床诊断 治疗进展 

分 类 号：R771.3[医药卫生—眼科] R593.2[医药卫生—临床医学]